AI infrastructure can't evolve as fast as model innovation. Memory architecture is one of the few levers capable of accelerating deployment cycles. Enter SOCAMM2 ...

For nearly two decades, two-dimensional (2D) semiconductors have been studied as a complement or possible successor to silicon transistors, promising smaller, faster and more energy-efficient ...

For nearly two decades, two‑dimensional (2D) semiconductors have been studied as a complement or possible successor to silicon transistors, promising ...

China’s brain-computer interface industry is growing fast, and the newest company to emerge from the country is aiming to access the brain without the use of invasive implants. Gestala, newly founded ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The HP Eliteboard G1a packs an AMD chip into a keyboard with either an attached or detachable USB-C cable. The HP Eliteboard G1a packs an AMD chip into a keyboard with either an attached or detachable ...

For American architecture, 2025 may be remembered for the deaths of icons Frank Gehry, Robert A. M. Stern and Ricardo Scofidio, a mastermind of New York’s High Line. More likely, however, it will go ...

Throughout 2025, enterprise software providers have launched and spoken of agentic AI, claiming it will revolutionise the operating model of organisations. With agents available in key enterprise ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

General Motors will start rolling out more powerful Nvidia computers on its vehicles 2028 onwards. The automaker is moving towards a centralized architecture which reduces the number of on-board ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...